Edition:
India

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

43.38CNY
19 Jan 2018
Change (% chg)

¥-0.36 (-0.82%)
Prev Close
¥43.74
Open
¥44.00
Day's High
¥44.13
Day's Low
¥42.62
Volume
17,128,421
Avg. Vol
20,772,900
52-wk High
¥47.58
52-wk Low
¥24.22

Chart for

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.71
Market Cap(Mil.): ¥83,213.47
Shares Outstanding(Mil.): 2,495.13
Dividend: 0.35
Yield (%): 1.02

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials

Jan 17 Shanghai Fosun Pharmaceutical Group Co Ltd

17 Jan 2018

BRIEF-Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm

Jan 10 Shanghai Fosun Pharmaceutical Group Co Ltd:

10 Jan 2018

BRIEF-Shanghai Fosun Pharmaceutical Group unit receives GMP certificate

Jan 1 Shanghai Fosun Pharmaceutical Group Co Ltd :

01 Jan 2018

BRIEF-Shanghai Fosun Pharmaceutical Group signs project investment framework agreement

Dec 29Shanghai Fosun Pharmaceutical Group Co Ltd :

29 Dec 2017

BRIEF-Shanghai Fosun Pharmaceutical Group unit gets approval for HLX10 clinical trail

Dec 21 Shanghai Fosun Pharmaceutical Group Co Ltd :

21 Dec 2017

BRIEF-Shanghai Fosun Pharmaceutical Group's Unit Enters Capital Increase Agreement

Dec 20 Shanghai Fosun Pharmaceutical Group Co Ltd:

20 Dec 2017

BRIEF-Shanghai Fosun Pharmaceutical Group Updates On JV Contract

Dec 20 Shanghai Fosun Pharmaceutical Group Co Ltd:

20 Dec 2017

Earnings vs. Estimates